GlobeImmune Relocates Corporate Headquarters (Chronic Hepatitis C)

GlobeImmune Relocates Corporate Headquarters
Pharma Live - LOUISVILLE, Colo., December 15, 2005 /PRNewswire/ -- GlobeImmune, Inc. today announced the relocation of its corporate headquarters to Louisville, Colorado. 1b trial for its second product, GI-5005, a Tarmogen for the treatment of chronic

Early treatment of
Aidsmap - Liver diseases including

Thousands infected with
999 Today - Around 4,500 people in England and Wales are living with severe liver disease, including cirrhosis, liver failure or liver cancer, as a result of having a chronic